| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.4 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.5 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |